Today's Stock Analyst Downgrades

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ADBE Adobe	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$238.14 -1.7%	$270.00 ➝ $225.00	Overweight ➝ Underweight
BWIN Baldwin Insurance Group	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Kligerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.85 -0.1%	$37.00 ➝ $32.50	Buy ➝ Hold
BWIN Baldwin Insurance Group	Downgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meyer Shields Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.85 -0.1%	$32.50	Outperform ➝ Market Perform
CHRW C.H. Robinson Worldwide	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$139.75 -1.8%	$153.00	Buy ➝ Hold
CRM Salesforce	Downgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$233.74 +2.0%		Overweight ➝ Positive
CRM Salesforce	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$233.74 +2.0%		Buy ➝ Underweight
HUBS HubSpot	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shebly Seyrafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$222.73 -2.4%	$240.00	Positive ➝ Cautious
HUBS HubSpot	Downgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$222.73 -2.4%	$240.00	Overweight ➝ Equal Weight
INSM Insmed	Downgraded by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andy Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$98.56 -2.0%		Outperform ➝ Peer Perform
MNDY monday.com	Downgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.76 -4.7%	$100.00	Overweight ➝ Equal Weight
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now.
PNN Pennon Group	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 323 -9.5%	GBX 550 ➝ GBX 380	Hold
RBLX Roblox	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.65 +3.2%		Overweight ➝ Cautious
ROIV Roivant Sciences	Downgraded by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andy Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.59 -2.4%		Outperform ➝ Peer Perform
UWMC UWM	Downgraded by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Douglas Harter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.03 -5.1%		Buy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 01:11 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Analyst Downgrades

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Analyst Downgrades

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools